| 1ABN | A: | THE CRYSTAL STRUCTURE OF THE ALDOSE REDUCTASE NADPH BINARY COMPLEX |
| 1ADS | A: | AN UNLIKELY SUGAR SUBSTRATE SITE IN THE 1.65 ANGSTROMS STRUCTURE OF THE HUMAN ALDOSE REDUCTASE HOLOENZYME IMPLICATED IN DIABETIC COMPLICATIONS |
| 1AZ1 | A: | ALRESTATIN BOUND TO C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASE |
| 1AZ2 | A: | CITRATE BOUND, C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASE |
| 1EF3 | A:; B: | FIDARESTAT BOUND TO HUMAN ALDOSE REDUCTASE |
| 1EL3 | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH IDD384 INHIBITOR |
| 1IEI | A: | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE INHIBITOR ZENARESTAT. |
| 1MAR | A: | REFINED 1.8 ANGSTROMS STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE POTENT INHIBITOR ZOPOLRESTAT |
| 1PWL | A: | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND MINALRESTAT |
| 1PWM | A: | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND FIDARESTAT |
| 1T40 | A: | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND IDD552 AT PH 5 |
| 1T41 | A: | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND IDD552 |
| 1US0 | A: | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR IDD594 AT 0.66 ANGSTROM |
| 1X96 | A: | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE WITH CITRATES BOUND IN THE ACTIVE SITE |
| 1X97 | A: | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH 2R4S (STEREOISOMER OF FIDARESTAT, 2S4S) |
| 1X98 | A: | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH 2S4R (STEREOISOMER OF FIDARESTAT, 2S4S) |
| 1XGD | A: | APO R268A HUMAN ALDOSE REDUCTASE |
| 1ZUA | X: | CRYSTAL STRUCTURE OF AKR1B10 COMPLEXED WITH NADP+ AND TOLRESTAT |
| 2ACQ | A: | AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRATE, CACODYLATE, AND GLUCOSE-6-PHOSPHATE |
| 2ACR | A: | AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRATE, CACODYLATE, AND GLUCOSE-6-PHOSPHATE |
| 2ACS | A: | AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRATE, CACODYLATE, AND GLUCOSE-6-PHOSPHATE |
| 2ACU | A: | TYROSINE-48 IS THE PROTON DONOR AND HISTIDINE-110 DIRECTS SUBSTRATE STEREOCHEMICAL SELECTIVITY IN THE REDUCTION REACTION OF HUMAN ALDOSE REDUCTASE: ENZYME KINETICS AND THE CRYSTAL STRUCTURE OF THE Y48H MUTANT ENZYME |
| 2AGT | A: | ALDOSE REDUCTASE MUTANT LEU 300 PRO COMPLEXED WITH FIDARESTAT |
| 2ALR | A: | ALDEHYDE REDUCTASE |
| 2F2K | A: | ALDOSE REDUCTASE TERTIARY COMPLEX WITH NADPH AND DEG |
| 2FZ8 | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH INHIBITOR ZOPOLRESTAT AT 1.48 A(1 DAY SOAKING). |
| 2FZ9 | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH INHIBITOR ZOPOLRESTAT AFTER SIX DAYS SOAKING. |
| 2FZB | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH FOUR TOLRESTAT MOLECULES AT 1.5 A RESOLUTION. |
| 2FZD | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH TOLRESTAT AT 1.08 A RESOLUTION. |
| 2INE | A: | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH PHENYLACETIC ACID |
| 2INZ | A: | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH 2-HYDROXYPHENYLACETIC ACID |
| 2IPW | A: | CRYSTAL STRUCTURE OF C298A W219Y ALDOSE REDUCTASE COMPLEXED WITH DICHLOROPHENYLACETIC ACID |
| 2IQ0 | A: | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH HEXANOIC ACID |
| 2IQD | A: | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH LIPOIC ACID |
| 2IS7 | A: | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH DICHLOROPHENYLACETIC ACID |
| 2ISF | A: | CRYSTAL STRUCTURE OF C298A W219Y ALDOSE REDUCTASE COMPLEXED WITH PHENYLACETIC ACID |
| 2PD5 | A: | HUMAN ALDOSE REDUCTASE MUTANT V47I COMPLEXED WITH ZOPOLRESTAT |
| 2PD9 | A: | HUMAN ALDOSE REDUCTASE MUTANT V47I COMPLEXED WITH FIDARESTAT. |
| 2PDB | A: | HUMAN ALDOSE REDUCTASE MUTANT F121P COMPLEXED WITH ZOPOLRESTAT. |
| 2PDC | A: | HUMAN ALDOSE REDUCTASE MUTANT F121P COMPLEXED WITH IDD393. |
| 2PDF | A: | HUMAN ALDOSE REDUCTASE MUTANT L300P COMPLEXED WITH ZOPOLRESTAT. |
| 2PDG | A: | HUMAN ALDOSE REDUCTASE WITH URACIL-TYPE INHIBITOR AT 1.42A. |
| 2PDH | A: | HUMAN ALDOSE REDUCTASE MUTANT L300P COMPLEXED WITH URACIL-TYPE INHIBITOR AT 1.45 A. |
| 2PDI | A: | HUMAN ALDOSE REDUCTASE MUTANT L300A COMPLEXED WITH ZOPOLRESTAT AT 1.55 A. |
| 2PDJ | A: | HUMAN ALDOSE REDUCTASE MUTANT L300A COMPLEXED WITH IDD393. |
| 2PDK | A: | HUMAN ALDOSE REDUCTASE MUTANT L301M COMPLEXED WITH SORBINIL. |
| 2PDL | A: | HUMAN ALDOSE REDUCTASE MUTANT L301M COMPLEXED WITH TOLRESTAT. |
| 2PDM | A: | HUMAN ALDOSE REDUCTASE MUTANT S302R COMPLEXED WITH ZOPOLRESTAT. |
| 2PDN | A: | HUMAN ALDOSE REDUCTASE MUTANT S302R COMPLEXED WITH URACIL-TYPE INHIBITOR. |
| 2PDP | A: | HUMAN ALDOSE REDUCTASE MUTANT S302R COMPLEXED WITH IDD 393. |
| 2PDQ | A: | HUMAN ALDOSE REDUCTASE MUTANT C303D COMPLEXED WITH URACIL-TYPE INHIBITOR. |
| 2PDU | A: | HUMAN ALDOSE REDUCTASE MUTANT C303D COMPLEXED WITH IDD393. |
| 2PDW | A: | HUMAN ALDOSE REDUCTASE MUTANT C303D COMPLEXED WITH FIDARESTAT. |
| 2PDX | A: | HUMAN ALDOSE REDUCTASE DOUBLE MUTANT S302R-C303D COMPLEXED WITH ZOPOLRESTAT. |
| 2PDY | A: | HUMAN ALDOSE REDUCTASE DOUBLE MUTANT S302R-C303D COMPLEXED WITH FIDARESTAT. |
| 2PEV | A: | COMPLEX OF ALDOSE REDUCTASE WITH NADP+ AND SIMALTANEOUSLY BOUND COMPETETIVE INHIBITORS FIDARESTAT AND IDD594. CONCENTRATION OF FIDARESTAT IN SOAKING SOLUTION EXCEEDS CONCENTRATION OF IDD594. |
| 2PF8 | A: | COMPLEX OF ALDOSE REDUCTASE WITH NADP+ AND SIMALTANEOUSLY BOUND COMPETETIVE INHIBITORS FIDARESTAT AND IDD594. CONCENTRATION OF FIDARESTAT IN SOAKING SOLUTION IS EQUAL TO CONCENTRATION OF IDD594. |
| 2PFH | A: | COMPLEX OF ALDOSE REDUCTASE WITH NADP+ AND SIMALTANEOUSLY BOUND COMPETETIVE INHIBITORS FIDARESTAT AND IDD594. CONCENTRATION OF FIDARESTAT IN SOAKING SOLUTION IS LESS THAN CONCENTRATION OF IDD594. |
| 2PZN | A: | THE CRYSTALLOGRAPHIC STRUCTURE OF ALDOSE REDUCTASE IDD393 COMPLEX CONFIRMS LEU300 AS A SPECIFICITY DETERMINANT |
| 3DN5 | A: | ALDOSE REDUCTASE IN COMPLEX WITH NOVEL BIARYLIC INHIBITOR |
| 3G5E | A: | HUMAN ALDOSE REDUCTASE COMPLEXED WITH IDD 740 INHIBITOR |
| 3GHR | A: | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR IDD594. INVESTIGATION OF GLOBAL EFFECTS OF RADIATION DAMAGE ON PROTEIN STRUCTURE. FIRST STAGE OF RADIATION DAMAGE |
| 3GHS | A: | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR IDD594. INVESTIGATION OF GLOBAL EFFECTS OF RADIATION DAMAGE ON PROTEIN STRUCTURE. SECOND STAGE OF RADIATION DAMAGE. |
| 3GHT | A: | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR IDD594. INVESTIGATION OF GLOBAL EFFECTS OF RADIATION DAMAGE ON PROTEIN STRUCTURE. THIRD STAGE OF RADIATION DAMAGE. |
| 3GHU | A: | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR IDD594. INVESTIGATION OF GLOBAL EFFECTS OF RADIATION DAMAGE ON PROTEIN STRUCTURE. FORTH STAGE OF RADIATION DAMAGE. |
| 3LBO | A: | HUMAN ALDOSE REDUCTASE MUTANT T113C COMPLEXED WITH IDD594 |
| 3LD5 | A: | HUMAN ALDOSE REDUCTASE MUTANT T113S COMPLEXED WITH IDD594 |
| 3LEN | A: | HUMAN ALDOSE REDUCTASE MUTANT T113S COMPLEXED WITH ZOPOLRESTAT |
| 3LEP | A: | HUMAN ALDOSE REDUCTASE MUTANT T113C IN COMPLEX WITH IDD388 |
| 3LQG | A: | HUMAN ALDOSE REDUCTASE MUTANT T113A COMPLEXED WITH IDD388 |
| 3LQL | A: | HUMAN ALDOSE REDUCTASE MUTANT T113A COMPLEXED WITH IDD 594 |
| 3LZ3 | A: | HUMAN ALDOSE REDUCTASE MUTANT T113S COMPLEXED WITH IDD388 |
| 3LZ5 | A: | HUMAN ALDOSE REDUCTASE MUTANT T113V COMPLEXED WITH IDD594 |
| 3M0I | A: | HUMAN ALDOSE REDUCTASE MUTANT T113V IN COMPLEX WITH ZOPOLRESTAT |
| 3M4H | A: | HUMAN ALDOSE REDUCTASE MUTANT T113V COMPLEXED WITH IDD388 |
| 3M64 | A: | HUMAN ALDOSE REDUCTASE MUTANT T113V COMPLEXED WITH IDD393 |
| 3MB9 | A: | HUMAN ALDOSE REDUCTASE MUTANT T113A COMPLEXED WITH ZOPOLRESTAT |
| 3MC5 | A: | HUMAN ALDOSE REDUCTASE MUTANT T113V IN COMPLEX WITH IDD393 CRYSTALLIZED IN SPACEGROUP P1 |
| 3ONB | A: | BOND BREAKAGE AND RELOCATION OF A COVALENTLY BOUND BROMINE OF IDD594 IN A COMPLEX WITH HAR T113A MUTANT AFTER EXTENSIVE RADIATION DOSE |
| 3ONC | A: | BOND BREAKAGE AND RELOCATION OF A COVALENTLY BOUND BROMINE OF IDD594 IN A COMPLEX WITH HAR T113A MUTANT AFTER MODERATE RADIATION DOSE |
| 3P2V | A: | NOVEL BENZOTHIAZEPINE INHIBITOR IN COMPLEX WITH HUMAN ALDOSE REDUCTASE |
| 3Q65 | A:; B: | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ IN SPACE GROUP P212121 |
| 3Q67 | A:; B: | HUMAN ALDOSE REDUCTASE C298S MUTANT IN COMPLEX WITH NADP+ IN SPACE GROUP P212121 |
| 3RX2 | A: | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH SULINDAC SULFONE |
| 3RX3 | A: | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH SULINDAC |
| 3RX4 | A: | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH SULINDAC SULFIDE |
| 3S3G | A: | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH TOLMETIN |
| 3T42 | A: | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH A NITRILE-CONTAINING IDD INHIBITOR |
| 3V35 | A: | ALDOSE REDUCTASE COMPLEXED WITH A NITRO COMPOUND |
| 3V36 | A: | ALDOSE REDUCTASE COMPLEXED WITH GLCERALDEHYDE |
| 4GCA | A: | COMPLEX OF ALDOSE REDUCTASE WITH INHIBITOR IDD 1219 |
| 4GQ0 | A: | CRYSTAL STRUCTURE OF AKR1B10 COMPLEXED WITH NADP+ AND CAFFEIC ACID PHENETHYL ESTER |
| 4GQG | A: | CRYSTAL STRUCTURE OF AKR1B10 COMPLEXED WITH NADP+ |
| 4I5X | A: | CRYSTAL STRUCTURE OF AKR1B10 COMPLEXED WITH NADP+ AND FLUFENAMIC ACID |
| 4IGS | A: | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP+ AND JF0064 |
| 4JIR | A: | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE (AKR1B1) COMPLEXED WITH NADP+ AND EPALRESTAT |
)
)